Ad
ABT - Abbott Laboratories Stock Trading
About | Abbott Laboratories (NYSE:ABT)
Not available
Quote | Abbott Laboratories (NYSE:ABT)
| Last: | $104.51 |
|---|---|
| Change Percent: | -0.07% |
| Open: | $104.12 |
| Close: | $104.51 |
| High: | $104.86 |
| Low: | $104.12 |
| Volume: | 3,418,477 |
| Last Trade Date Time: | 12/08/2023 03:00:00 am |
News | Abbott Laboratories (NYSE:ABT)
-
2023-12-10 10:00:00 ET Summary Mr. Market has overemphasized the potential negative impacts of GLP-1 drugs on conventional diabetes care since there is no miracle one-time drug. Medtronic's bottom lines have also been impacted by the elevated inflationary pressure and FX headwinds...
-
2023-12-08 08:45:00 ET As the year draws to a close, it's as good a time as any to review one's investments and consider adding more money into the stock market. The goal shouldn't be to take advantage of the January effect -- the tendency equities have to rise early in the year. These mark...
Message Board Posts | Abbott Laboratories (NYSE:ABT)
| Subject | By | Source | When |
|---|---|---|---|
| $ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
| $ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
| $ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
| whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
| FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
Ad
-
2023-12-08 08:45:00 ET As the year draws to a close, it's as good a time as any to review one's investments and consider adding more money into the stock market. The goal shouldn't be to take advantage of the January effect -- the tendency equities have to rise early in the year. These mark...
-
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.25% on an annualized basis producing an average annual retur...
-
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.04% on an annualized basis producing an average annual retur...